Coexpression of integrin α(v)β3 and matrix metalloproteinase-2 (MMP-2) coincides with MMP-2 activation: Correlation with melanoma progression

Journal of Investigative Dermatology

Volumn 115, Issue 4, 2000, Pages 625-632

  Hofmann, Uta B ^a,b   Westphal, Johan R ^a   Waas, Erwin T ^a   Becker, Jürgen C ^b   Ruiter, Dirk J ^a   Van Muijen, Goos N P ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Invasion; Matrix metalloproteinase 2; Melanoma; Xenograft

Indexed keywords

COMPLEMENTARY DNA; GELATINASE A; INTEGRIN; MATRIX METALLOPROTEINASE; RNA; TISSUE INHIBITOR OF METALLOPROTEINASE;

ARTICLE; CANCER INVASION; CONTROLLED STUDY; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MELANOMA; MELANOMA CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN CANCER;

EID: 0033774029     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2000.00114.x     Document Type: Article

References (46)

1. Integrin distribution in malignant melanoma: Association of the beta 3 subunit with tumor progression
2. Matrix metalloproteinases: A review
3. Localization of matrix metalloproteinase MMP- 2 to the surface of invasive cells by interaction with integrin alpha v beta 3
4. The TIMP2 membrane type 1 metalloproteinase 'receptor' regulates the concentration and efficient activation of progelatinase A. A kinetic study
5. Alpha v-integrins in human melanoma: Gain of alpha v beta 3 and loss of alpha v beta 5 are related to tumor progression in situ but not to metastatic capacity of cell lines in nude mice
6. Integrin beta 3 cDNA transfection into a highly metastatic alpha v beta 3-negative human melanoma cell line inhibits invasion and experimental metastasis
7. Matrix metalloproteinase- 2 activation modulates glioma cell migration
8. Involvement of integrin alpha v gene expression in human melanoma tumorigenicity
9. Requirement of the NPXY motif in the integrin beta 3 subunit cytoplasmic tail for melanoma cell migration in vitro and in vivo
10. Integrin expression in human melanoma cells with differing invasive and metastatic properties
11. Regulation of matrix metalloproteinases following cellular transformation
12. Matrix metalloproteinases in human melanoma cell lines and xenografts: Increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression
13. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its colocalization with membrane-type matrix metalloproteinase 1 (MT1-MMP) correlate with melanoma progression
14. 3 correlates with activation of membrane-type matrix metalloproteinase-1 (MT1-MMP) and matrix metalloproteinase-2 (MMP-2) in human melanoma cells in vitro and in vivo
15. Adenoviral gene transfer of beta3 integrin subunit induces conversion from radial to vertical growth phase in primary human melanoma
16. Integrins: Versatility, modulation, and signaling in cell adhesion
17. Prognostic values of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase- 2 expression in bladder cancer
18. Tissue inhibitor of matrix metalloproteinase-2 regulates matrix metalloproteinase-2 activation by modulation of membrane-type 1 matrix metalloproteinase activity in high and low invasive melanoma cell lines
19. Proteolytic processing of membrane-type- 1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface
20. Structure of human pro-matrix metalloproteinase-2: Activation mechanism revealed
21. Proteolysis and cell migration: Creating a path?
22. Cell surface activation of progelatinase A (proMMP-2) and cell migration
23. Transmembrane/cytoplasmic domain-mediated membrane type 1-matrix metalloprotease docking to invadopodia is required for cell invasion
24. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas
25. Clinical significance of alpha (v) beta3 integrin and intercellular adhesion molecule- 1 expression in cutaneous malignant melanoma lesions
26. The role of the integrin vitronectin receptor, alpha v beta 3 in melanoma metastasis
27. Human melanoma cells derived from lymphatic metastases use integrin alpha v beta 3 to adhere to lymph node vitronectin
28. Expression of membrane-type matrix metalloproteinase in human gastric carcinomas
29. Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrimic matrix-degrading activity
30. 3 promotes M21 melanoma growth in human skin by regulating tumor cell survival
31. Gelatinase A activity directly modulates melanoma cell adhesion and spreading
32. A matrix metalloproteinase expressed on the surface of invasive turnout cells
33. Role of the beta3 integrin subunit in human primary melanoma progression: Multifunctional activities associated with alpha (v) beta3 integrin expression
34. Role of the alpha v beta 3 integrin in human melanoma cell invasion
35. The 72kDa type IV collagenase is modulated via differential expression of alpha v beta 3 and alpha 5 beta 1 integrins during human melanoma cell invasion
36. Divergent patterns of matrix metalloproteinase activity during wound healing in ileum and colon of rats
37. Tumor cell interactions with the extracellular matrix during invasion and metastasis
38. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease
39. Activation of the precursor of gelatinase A/72kDa type 1V collagenase/MMP-2 in lung carcinomas correlates with the expression of membrane-type matrix metalloproteinase (MT-MMP) and with lymph node metastasis
40. Matrix metalloproteinase-2 (72kD type IV collagenase) expression occurs in the early stage of human melanocytic tumour progression and may have prognostic value
41. Prognostic value of MMP-2 immunoreactive protein (72kD type IV collagenase) in primary skin melanoma
42. Antigen expression of metastasizing and non-metastasizing human melanoma cells xenografted into nude mice
43. Establishment and characterization of a human melanoma cell line (MV3) which is highly metastatic in nude mice
44. Matrix metalloproteinases and their inhibitors in connective tissue remodeling
45. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro
46. Tissue inhibitor of metalloproteinase-2 (TIMP-2) binds to the catalytic domain of the ceil surface receptor, membrane type 1-matrix metalloproteinase 1 (MT1-MMP)